Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

被引:48
作者
Gilmore, JL
Hays, SJ
Caprathe, BW
Lee, C
Emmerling, MR
Michael, W
Jaen, JC
机构
[1] Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105
关键词
D O I
10.1016/0960-894X(96)00094-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-aryl-4H-3,1-benzoxazin-4-ones have been synthesized and tested for inhibitory activity against Clr serine protease. Compounds were found that were equipotent and more selective than the reference compound FUT-175.
引用
收藏
页码:679 / 682
页数:4
相关论文
共 10 条
[1]   PHARMACOLOGICAL STUDIES OF FUT-175, NAFAMSTAT MESILATE .1. INHIBITION OF PROTEASE ACTIVITY IN INVITRO AND INVIVO EXPERIMENTS [J].
AOYAMA, T ;
INO, Y ;
OZEKI, M ;
ODA, M ;
SATO, T ;
KOSHIYAMA, Y ;
SUZUKI, S ;
FUJITA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (03) :203-227
[2]  
BAIN DT, 1968, J CHEM SOC, V13, P1593
[3]  
JIANG HX, 1994, J IMMUNOL, V152, P5050
[4]   REACTIONS OF THE IMMUNE-SYSTEM IN CHRONIC DEGENERATIVE NEUROLOGICAL DISEASES [J].
MCGEER, PL ;
MCGEER, EG ;
KAWAMATA, T ;
YAMADA, T ;
AKIYAMA, H .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 18 (03) :376-379
[5]   IMMUNE-SYSTEM RESPONSE IN ALZHEIMERS-DISEASE [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1989, 16 (04) :516-527
[6]  
MCRAE BJ, 1981, J BIOL CHEM, V23, P256
[7]   COMPLEMENT ACTIVATION BY BETA-AMYLOID IN ALZHEIMER-DISEASE [J].
ROGERS, J ;
COOPER, NR ;
WEBSTER, S ;
SCHULTZ, J ;
MCGEER, PL ;
STYREN, SD ;
CIVIN, WH ;
BRACHOVA, L ;
BRADT, B ;
WARD, P ;
LIEBERBURG, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10016-10020
[8]  
ROMLINSON S, 1991, IMMUNOLOGY SHORT COU, P135
[9]  
SCOTT CW, 1994, DRUG NEWS PERSPECT, V7, P269
[10]   COMPLEMENT DEFENSE-MECHANISMS [J].
TOMLINSON, S .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (01) :83-89